The French national institute of health and medical research is celebrating its 50th anniversary in 2014. Below you will see a list of the first key events this year.
30: Publication of the book Au Cœur du Vivant (The Heart of the Living), published by Cherche-midi
14: Launch of 4-D film attraction Virus Attack at the Futuroscope, Poitiers.
10: First stage of the Science Tour (Vannes). A fleet of educational entertainment trucks will tour France to meet the public.
14: Press conference to launch the 50th anniversary of Inserm at the Futuroscope, Poitiers.
21: The first of 4 “Researchers welcoming patients” gatherings, on the theme of kidney diseases. 22 research teams in Strasbourg, Nantes, Toulouse, Marseille, Nice and Paris will open their laboratory doors to patient associations.
8–17 March: Famelab, regional selection stages. 3 minutes to use your powers of persuasion and become the new face of science. This competition for young researchers will be held in France for the first time, in partnership with Inserm.
3: Grand Colloquium to celebrate the 50th anniversary of Inserm at the Sorbonne, under the patronage of the President of France.
13: Clinical Research gathering in Lyon.
14: Inserm’s 50th anniversary is featured in the 2014 edition of Futurapolis, the forum for technological and scientific innovation in Toulouse.
16: Destination lab: 50 research laboratories will open their doors to the public all over France.
23: Second “Researchers welcoming patients” gathering, all over France, on the theme of rare diseases.
3: Launch of a stamp to commemorate the 50th anniversary of Inserm.
18: 50th anniversary of Inserm, created in 1964 by the amalgamation of the French Institute of Hygiene and the Claude Bernard Association.
Welcome of the President François MITTERRAND by Philippe LAZAR, CEO of Inserm and Professor Jean BERNARD during the creation of the National Ethics Committee. ©M Depardieu/Inserm
L’Inserm et le fonds de dotation Pfizer Innovation France annoncent la création d’un dispositif de formation à la recherche en biologie/santé à destination des élèves des écoles d’ingénieurs : l’École de l’Inserm-Pfizer Innovation (EIPI). ...
La France, forte de l’excellence de sa recherche clinique en matière de vaccination s’est organisée pour contribuer à l’évaluation des candidats vaccins contre la Covid-19 les plus prometteurs via la plateforme COVIREIVAC de l’Inserm. Trois essais cliniques vaccinaux devraient démarrer en France ...